Targeting the murine serotonin transporter: insights into human neurobiology

Dennis L. Murphy,Klaus-Peter Lesch

DOI: https://doi.org/10.1038/nrn2284

IF: 38.755

2008-02-01

Nature Reviews Neuroscience

Abstract:Key PointsSerotonin's suspected involvement in emotions such as anxiety and depression in behavioural and neuropsychiatric disorders, as well as in many physiological processes, has been suggested by indirect evidence over many decades.More recently, specific evidence of a major role for serotonin in human disorders was obtained from evaluations of gene variants, such as the 5-HTTLPR in the gene that encodes the serotonin transporter (SERT), in human lymphoblasts, as well as from studies of post-mortem brain tissue and dynamic brain imaging of SERT.Even stronger evidence of the roles of serotonin and SERT has emerged over the past decade from the use of genetic engineering technologies to produce partially and completely SERT-deficient mice and mice that overexpress SERT.Anxiety-like behaviours and other behaviours, as well as over 50 different changes in brain serotonin homeostasis, have been documented in these mice. These were accompanied by differential responses to anti-anxiety and antidepressant drugs, as well as brain anatomical and physiological changes.Some of these changes are different from those that are produced by selective serotonin reuptake inhibitors (SSRIs; drugs that inhibit SERT and act as antidepressant and anti-anxiety agents when given to adults). Other changes are congruent with the effects of SSRIs that are given early in the postnatal period, helping to confirm that there is a developmental role for many of the changes that are found in mice with genetically altered SERT — especially when gene–environment and gene–gene effects are taken into account.

neurosciences